AG2R LA MONDIALE Adopts Akur8 to Challenge Its Approach to Health Insurance Pricing
29.6.2021 10:00:00 EEST | Business Wire | Press release
AG2R LA MONDIALE and Akur8 are delighted to announce their collaboration to transform AG2R LA MONDIALE's health insurance pricing process. This move underlines AG2R LA MONDIALE's desire to encourage innovation for the benefit of its policyholders. It also reinforces Akur8's relevance in the health insurance sector.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210629005016/en/
Specifically developed for insurance companies, Akur8's solution enhances their pricing process by automating risk and demand modeling, using a proprietary technology powered by transparent artificial intelligence. Akur8 enables insurers to significantly reduce modeling times, speed up time-to-market and increase predictive power of their models, while retaining absolute transparency and control.
With Akur8, AG2R LA MONDIALE is challenging its health insurance products’ pricing approach in order to offer its policyholders fairer, more transparent and more tailored prices.
"We are delighted to be opening this new chapter with AG2R LA MONDIALE. This move underlines their innovative spirit and ability to adapt constantly in order to serve their clients better, while putting digital transformation at the heart of their plans," said Samuel Falmagne, CEO of Akur8.
"This collaboration with AG2R LA MONDIALE marks a significant step forward in Akur8's continuous development. It reinforces the solution's relevance for health insurance and consolidates our presence in France," said Brune de Linares, Chief of Sales at Akur8.
"We are delighted to collaborate with Akur8. We are constantly seeking to provide better support to our policyholders, in an environment that calls for ever more agility and adaptability. This experimentation with Akur8 is a prime example of this approach. We hope that this unique, intuitive and innovative solution will provide value in the key process of pricing," said Anne-Charlotte de Raigniac, Director of actuarial services and medical approvals at AG2R LA MONDIALE.
About AG2R LA MONDIALE:
As a specialist in social and patrimonial protection in France, AG2R LA MONDIALE insures individuals, businesses and professional branches, providing health protection, protecting assets and income, guarding against accidents and preparing for retirement. The Group has over 15 million policyholders and provides day-to-day support to 500,000 businesses. With more than 11,000 employees, AG2R LA MONDIALE has a presence throughout mainland France and beyond. As a partnership with joint, cooperative governance, the Group cultivates a unique social protection model that closely combines profitability and solidarity, performance and social commitment. Every year it spends millions of euros helping vulnerable people and supporting individual and collaborative initiatives.
Stay up to date: www.ag2rlamondiale.fr / @AG2RLAMONDIALE
About Akur8
Akur8 revolutionizes insurance pricing with transparent AI. Akur8 has developed a unique AI-based insurance pricing solution that automates modeling for insurance companies while keeping full transparency and control over the models created, as required by regulators worldwide. Akur8 is the only solution on the market that reconciles the Machine Learning and Actuarial worlds.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210629005016/en/
Contact information
Press Contacts
For Akur8
Anne-Laure Klein
+33 (0)6 63 79 44 74
anne-laure.klein@akur8-tech.com
For AG2R LA MONDIALE
Mélissa Bourguignon
+33 (0)6 04 52 18 63
melissa.bourguignon@ag2rlamondiale.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Delivers Fourth Quantum Computer in Finland, Operational at Aalto University11.3.2026 12:32:00 EET | Press release
IQM Quantum Computers, the global leader in deployed on-premises, full-stack superconducting quantum computers, today announced the launch of Aalto Q20 quantum computer in Finland, reinforcing its commercial leadership in the quantum industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311215316/en/ Ribbon cutting of the Aalto Q20 quantum computer delivered by IQM. The 20-qubit system, which is operational at Aalto University, is the fourth quantum computer deployed by IQM in Finland, marking a milestone in the country’s growing quantum technology ecosystem. Finland has recently been characterized as the number two global quantum cluster and is amongst the top five countries for quantum patent applications. “When institutions like Aalto University own their quantum computers, it means their data, their IP, and their expertise stay theirs. That’s not a feature — that’s a strategic posture to enable world-class research
Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site11.3.2026 12:00:00 EET | Press release
Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311319953/en/ Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler
NTT DATA Unveils NVIDIA-Powered Enterprise AI Factories to Support Secure AI Adoption and Help Clients Drive Measurable ROI11.3.2026 12:00:00 EET | Press release
NTT DATA, a global leader in AI, digital business and technology services, announced an initiative to deliver NVIDIA-powered enterprise AI factories that drive innovation and operational excellence for organizations worldwide. NTT DATA’s new enterprise AI factories provide full-stack, domain-specific solutions that integrate data, infrastructure, workflows and governance to give organizations a repeatable and production-ready operating model for enterprise AI. NTT DATA enterprise AI factories, powered by NVIDIA, are adaptive, intelligent and automated ecosystems designed to help clients accelerate return on investment by scaling enterprise AI efficiently and managing the full AI lifecycle end to end. The company’s new enterprise AI factories integrate the NVIDIA AI infrastructure—combining GPU-accelerated computing and high-performance networking—with NVIDIA AI Enterprise software, including NVIDIA NIM microservices, to deliver high‑throughput, low‑latency AI that can be deployed consi
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health11.3.2026 11:00:00 EET | Press release
Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio – which includes the global brands Sensodyne and parodontax – into China’s fast-growing tier 2 and tier 3 cities, where rising incomes, growing awareness of everyday health and a shift towards trusted, branded products are reshaping consumer behaviour. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311389622/en/ parodontax, Haleon's clinically proven gum health brand, is expanding across China As part of this shift, more consumers are embedding preventative oral care into their daily self-care routines, and demand for premium, science-backed solutions is accelerating at a rapid pace. This investment strengthens Haleon’s local manufacturing footprint and positions the business to capture
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples11.3.2026 10:00:00 EET | Press release
Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expertise to reducing diagnostic uncertainty with solutions that support clinicians and laboratories nationwide and internationally. Eurofins Biomnis has fully validated the method for human stool samples, taking into account matrix effects and meeting the requirements of ISO 15189 (with the exception of inter‑method comparison on pathological clinical samples). Cereulide, a toxin produced by specific strains of Bacillus cereus, has recently raised significant public attention following contamination events involving infant formula
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom